USPH U.S. Physical Therapy, Inc.
HealthcareAs of 2026-05-25
Valuation
View DetailsP/E (TTM)
73.86
PEG
—
P/B
2.00
P/S
1.29
EV/EBITDA
12.15
DCF Value
$48.57
FCF Yield
7.1%
Div Yield
2.9%
Margins & Returns
Gross Margin
20.4%
Operating Margin
12.0%
Net Margin
0.2%
ROE
0.2%
ROA
0.1%
ROIC
5.5%
Financials
View All| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 null | $198.3M | $-4.3M | $— |
| Q4 null | $202.7M | $-10.5M | $— |
| FY null | $781.0M | $15.1M | $— |
| Q3 null | $164.0M | $7.2M | $— |
Analyst Ratings
View AllConsensus
Buy
Target (Consensus)
$96.00
Target (Median)
$96.00
Target Range
$90.00 - $102.00
Trading Activity
Insider Trades
View AllCompany Info
Sector
Healthcare
Industry
Medical - Care Facilities
Country
US
Exchange
—
Beta
1.20
U.S. Physical Therapy, Inc., through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. It operates through two segments, Physical Therapy Operations and Industrial Injury Prevention Services. The company offers industrial injury prevention services, including onsite injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments through physical therapists and specialized certified athletic trainers for Fortune 500 companies, and other clients comprising insurers and their contractors. As of December 31, 2021, it operated 591 clinics in 39 states; and managed 35 physical therapy practice facilities. The company was founded in 1990 and is based in Houston, Texas.